Fact sheet: BB Medtech

Fund information

Fund name
BB Medtech B EUR
Fund company manager
Bellevue Asset Management
Fund type
SIB
Fund manager(s)
Stefan Blum
since 30/09/2009
Marcel Fritsch
since 30/09/2009
Fund objective
The Fund’s investment objective is to generate attractive and competitive capital growth in the long term. It is therefore particularly suited to investors with an investment horizon of at least 5 years who want to selectively diversify their portfolio with investments in the medtech sector and who are willing to accept the equity risk typical of this sector.
Benchmark
MSCI Healthcare Equip. & Supp
Investment style
None
Investment method
Shares

Quick stats

1 Year return

17.71 %

1 Year rank in sector

11/29

Sector

FO Equity - Pharma Health & Biotech

Yield
-
Fund size

£ 198.7 m

FE Risk score

135

NAV
-
Discount/Premium
-
Gearing
-

Top in sector

Holdings snapshot

  • USA
    86.8%
  • Denmark
    4.6%
  • Netherlands
    2.5%
  • Japan
    2%
  • Others
    1.7%
  • Health Care
    81.5%
  • Others
    11.9%
  • Biotechnology/Medical
    5.3%
  • Money Market
    1.3%
  • US Equities
    86.8%
  • Danish Equities
    4.6%
  • Dutch Equities
    2.5%
  • Japanese Equities
    2%
  • International Equities
    1.7%

Performance vs. Sector

Cumulative performance

1m6m1y3y5y
Fund-1.81 %-0.48 %17.71 %37.7 %109.02 %
Sector-0.75 %1.48 %14.33 %8.05 %94.67 %
Rank within sector23 / 3021 / 3011 / 293 / 269 / 22
Quartile th4 th3 rd2 nd1 st2 nd

Calendar performance

YTD-20172016201520142013
Fund15.17 %6.5 %10.88 %35.42 %15.54 %
Sector13.01 %-9.92 %7.24 %28.08 %41.03 %
Rank within sector11 / 293 / 299 / 268 / 2322 / 22
Quartile th2 nd1 st2 nd2 nd4 th

Risk statistics

Alpha10.18
Beta0.7
Sharpe0.68
Volatility13.61
Tracking error9.93
Information ratio0.9
R-Squared0.61

Price movement

52 week high373.86
52 week low311.39
Current bid price0
Current offer price0
Current mid price363.43

Holdings by region

  • 86.8% USA
  • 4.6% Denmark
  • 2.5% Netherlands
  • 2% Japan
  • 1.7% Others
  • 1.3% Money Market
  • 1.1% Germany

Holdings by sector

  • 81.5% Health Care
  • 11.9% Others
  • 5.3% Biotechnology/Medical
  • 1.3% Money Market

Holdings by asset type

  • 86.8% US Equities
  • 4.6% Danish Equities
  • 2.5% Dutch Equities
  • 2% Japanese Equities
  • 1.7% International Equities
  • 1.3% Money Market
  • 1.1% German Equities

Individual holdings

  • 9.4% ABBOTT LABORATORIES
  • 7% BOSTON SCIENTIFIC CORP
  • 6.1% DANAHER CORP
  • 5.4% MEDTRONIC INC
  • 4.5% EDWARDS LIFESCIENCES CORP
  • 4.4% BAXTER INTERNATIONAL INC
  • 4.4% INTUITIVE SURGICAL INC
  • 4.2% STRYKER CORP
  • 4.2% ZIMMER BIOMET HLDGS INC
  • 3.7% GN STORE NORD